Novo Nordisk's oral GLP-1 drug met the main goal of ​a late-stage study ‌in children and adolescents aged 10 to 17 years with ...
EssilorLuxottica's shares fell on Thursday after the eyewear maker reported broadly in‑line quarterly results, doing little ...
Lululemon Athletica's shares fell 4% in premarket trade on Thursday, after the struggling retailer announced former top Nike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results